A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors

Clinical trial NCT07460375 · RECRUITING

Trial details

NCT number: NCT07460375
Sponsor: LigaChem Biosciences, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2026-08-01
Primary completion: 2030-02-01
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.